Analystreport

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) is now covered by analysts at B. Riley. They set a "buy" rating and a $3.50 price target on the stock.

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview